There is also a marked reduction in cutaneous synthesis of 25(OH) vitamin D. High serum FGF-23 levels have now been added to the list of these indicators, which can predict the severity and resistance of secondary hyperparathyroidism in dialysis patients [15,16]. The gene discussed is FGF23; the disease is secondary hyperparathyroidism.